CANCER SCIENCE

概述《癌症科学》(原日本癌症研究杂志)的目标是提出对肿瘤学家具有重大临床影响或可能改变肿瘤疾病概念的研究。该杂志发表原创文章和社论，给编辑的信件，评论文章和报告，描述在基础，转化和临床癌症领域的原创研究。学科类别包括:基础免疫学和临床免疫学致癌作用细胞、分子和干细胞生物学临床研究药物发现及运送流行病学和预防遗传学、基因组学和蛋白质组学炎症和病毒学病理学目标和范围《癌症科学》(原日本癌症研究杂志)是日本癌症协会的月刊。该杂志于1907年首次出版，继续发表原创文章、社论和给编辑的信件，描述基础、转化和临床癌症研究领域的原创研究。该杂志还接受报告和病例报告。癌症科学的目标是提出非常重要和及时的发现，对肿瘤学家有重要的临床影响，或可能改变肿瘤的疾病概念。如果没有新的发现可以添加到以前的报告中，该杂志将不会发表描述罕见肿瘤或疾病的病例报告;不同肿瘤的组合，没有新的肿瘤学研究提示发现;在没有提示数据来解释异常结果的情况下，已经知道的治疗效果显著。评审文章也可以发表。从2017年1月1日起，癌症科学将不接受任何烟草行业资助的工作。第一次决定的平均提交时间是17天!读者提供进入日本领先的肿瘤学会的成员，有16000名成员关键字肿瘤，癌症，日本癌症协会，癌症科学，癌症研究，姑息治疗，放射治疗抽象和索引信息农业生物科技新闻与信息(CABI)生物酶:当前生物科学的认识(爱思唯尔)生物文摘(Clarivate Analytics)生物预览(Clarivate Analytics)CAS:化学文摘服务(ACS)CSA生物科学数据库(ProQuest)CSA致癌基因与生长因子摘要(ProQuest)目前内容:临床医学(科莱恩分析)Embase(爱思唯尔)注意:健康经济评估数据库(Wiley-Blackwell)InfoTrac(盖尔Cengage)期刊引用报告/科学版(Clarivate Analytics)MEDLINE / PubMed (NLM)PubMed膳食补充剂子集(NLM)科学引文索引(Clarivate Analytics)科学引文索引扩展(Clarivate Analytics)斯高帕斯(爱思唯尔)

OverviewCancer Science (formerly Japanese Journal of Cancer Research) aims to present research that has a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal publishes original articles and editorials, letters to the editor, review articles and reports describing original research in the fields of basic, translational and clinical cancer. Subject categories include: Basic and Clinical Immunology Carcinogenesis Cell, Molecular, and Stem Cell Biology Clinical Research Drug Discovery and Delivery Epidemiology and Prevention Genetics, Genomics, and Proteomics Inflammation and Virology PathologyAims and ScopeCancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.Effective from 1 January 2017, Cancer Science will not accept work that is funded in any part by tobacco industry sources.Average submission to first decision is 17 days!ReadershipOffers access to members of Japan''''''''s leading oncology society, with 16,000 membersKeywordsoncology, cancer, Japanese Cancer Association, Cancer Science, cancer research, palliative care, radiotherapyAbstracting and Indexing Information AgBiotech News & Information (CABI) BIOBASE: Current Awareness in Biological Sciences (Elsevier) Biological Abstracts (Clarivate Analytics) BIOSIS Previews (Clarivate Analytics) CAS: Chemical Abstracts Service (ACS) CSA Biological Sciences Database (ProQuest) CSA Oncogenes & Growth Factors Abstracts (ProQuest) Current Contents: Clinical Medicine (Clarivate Analytics) Embase (Elsevier) HEED: Health Economic Evaluations Database (Wiley-Blackwell) InfoTrac (GALE Cengage) Journal Citation Reports/Science Edition (Clarivate Analytics) MEDLINE/PubMed (NLM) PubMed Dietary Supplement Subset (NLM) Science Citation Index (Clarivate Analytics) Science Citation Index Expanded (Clarivate Analytics) SCOPUS (Elsevier)